BranchLab Raises $26 Million Series A Led by McKesson Ventures

May 13, 2026
BranchLab has secured $26 million in Series A funding led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, to expand its AI platform for pharmaceutical commercialization.

BranchLab has raised $26 million in Series A funding led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, announced in a press release. The round brings the company’s total funding to $35 million.

BranchLab provides an AI platform that helps pharmaceutical companies identify, segment, and activate patient and healthcare professional audiences. The platform enables teams to act on aggregated, privacy-safe data in near real time, improving marketing efficiency and reducing reliance on manual processes.

At the core of BranchLab’s system is a transformer-based architecture that trains models within customer-controlled environments. Only non-sensitive demographic and media data are deployed, allowing faster and compliant activation of campaigns. The company reports that its platform has delivered an average 70% improvement in marketing efficacy across multiple therapeutic areas.

With the new funding, BranchLab plans to expand enterprise deployments, strengthen integrations across healthcare and media systems, and continue developing its unified AI platform for pharmaceutical commercialization.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

05/13
SOPHiA GENETICS and Synnovis Partner to Expand Blood-Based Cancer Testing in the UK
05/13
Cellular Intelligence Acquires Novo Nordisk Parkinson's Cell Therapy Program
05/13
Elsevier Report Finds Nurses Underrepresented in Clinical AI Adoption
05/13
VentriPoint Diagnostics Showcases AI Cardiac Imaging Platform at AEPC 2026
05/13
Aon Expands Claims Copilot Platform Globally

More from: Funding

05/13
H.I.G. Capital Portfolio Company Avanta Salud to Acquire Vitaly Group
05/13
Vector Raises $10 Million Series A for AI Advertising Platform for B2B Marketers
05/13
UFOFLEET Acquires FleetMaster from Cox Automotive
05/13
Cerebras Raises IPO Price Range Again as Investor Demand Surges
05/13
Anthropic Warns Against Unauthorized Stock Sales on Secondary Platforms

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like